• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Analysis of tyrosine kinase chimeric gene

Research Project

Project/Area Number 13671057
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNagoya University

Principal Investigator

EMI Nobuhiko  Nagoya University Hospital, Assistant Professor, 医学部附属病院, 講師 (30185144)

Co-Investigator(Kenkyū-buntansha) YOKOZAWA Toshiya  Nagoya University Hospital, Medical Staff, 医学部附属病院, 医員
Project Period (FY) 2001 – 2002
KeywordsLeukemia / SYK / Tyrosine kinase / PDGFR / CEV
Research Abstract

We here investigate the intracellular signal transduction of the stable transfectants. TEL-Syk fusion protein was associated with p85 subunit of phosphatidyl inositol 3 kinase (PI3-K) followed by the activation of Akt in the absence of IL-3. Vav, phospholipase C-γ2 (PLC-γ2) and mitogen-activated protein kinase (MAPK) were also constitutively activated. TEL-Syk also activated signal transducer and activator of transcription (STAT) 5 in the absence of Janus kinase 2 (JAK2) activation. None of these kinases were phosphorylated in the BaF3 cell transfected with TELΔPNT-Syk in which the oligomerization domain of TEL was deleted. Piceatannol, the Syk specific kinase inhibitor, inhibited the activation of STAT5 and the growth of the TEL-Syk transformed cell. These data suggest that TEL-Syk fusion protein in cytoplasm leads to constitutive activation of PI3-K, PLC-γ, MAPK and STAT5 signal pathways which are closely involved in IL-3 independent cell proliferation of BaF3 cells.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] KUNO Yoshie et al.: "Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12) (q22;p12)"BLOOD. 97. 1050-1055 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] KOHNO Akio: "Acute Promyelocytic Leukemia with Apparently Normal Karyotype : Molecular Findings and Response to All-Trans Retinoic Acid"Leukemia and Lymphoma. 42. 151-161 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] KANBE Eiki: "Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells"International Journal of HEMATOLOGY. 74. 309-315 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Eiki Kanbe: "DR1-like Element in Human Topoisomerase IIa Gene involved in Enhancement of Etoposide-induced Apoptosis by PPARg ligand"Experimantal hematology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] KUNO Yoshie, ABE Akihiro, EMI Nobuhiko, IIDA Minako, YOKOZAWA Toshiya, TOWATARI Masayuki, TANIMOTO Mitsune, SAITO Hidehiko: "Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t (9 ; 12) (q22 ; p12)"BLOOD. 97. 1050-1055 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] KOHNO Akio, TSUZUKI Shinobu, KASAI Masanobu, MIYAMURA Koichi, EMI Nobuhiko, TANIMOTO Mitsune, SAITO Hidehiko: "Acute Promyelocytic Leukemia with Apparently Normal Karyotype : Molecular Findings and Response to All-Trans Retinoic Acid"Leukemia and Lymphoma. 42. 151-161 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] KANBE Eiki, EMI Nobuhiko, ABE Akihiro, TANAKA Hidehiko, KOBAYASHI Kazukiyo, SAITO Hidehiko: "Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells"International Journal of HEMATOLOGY. 74. 309-315 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Eiki Kanbe, Akihiro Abe, Masayuki Towatari, Hidehiko Saito, Nobuhiko Emi: "DR1-like Element in Human Topoisomerase IIa Gene involved in Enhancement of Etoposide-induced Apoptosis by PPARg ligand"Experimantal hematology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi